Indian Journal of Ophthalmology

SYMPOSIUM - TRIP
Year
: 2014  |  Volume : 62  |  Issue : 1  |  Page : 88--92

Changing paradigms of anti-VEGF in the Indian scenario


P Mahesh Shanmugam 
 Vitre o-retinal and Ocular Oncology Services, Sankara Eye Hospitals, Bangalore, India

Correspondence Address:
P Mahesh Shanmugam
Vitreo-retinal and Ocular Oncology Services, Sankara Eye Hospitals, Bangalore
India

Anti-vascular endothelial growth factors (VEGF) agents have revolutionized the treatment of retinal diseases. Use of anti-VEGF agents in the Indian Scenario present some unique challenges considering the absence of compounding pharmacies, poor penetrance of health insurance and limited affordability of the citizens of a developing economy. To study the changing paradigms of anti-VEGF use in the Indian scenario, all articles published by Indian authors, data from web-based surveys amongst Indian vitreo-retinal specialists were reviewed. In the paucity of compounding pharmacies in India, fractionation and injection techniques differ from those of developed countries. Frequent anti-VEGF monotherapy offers the best anatomical and visual results, but economics of scale do not allow the same in the Indian scenario, resulting in PRN dosing and combination of anti-VEGF with laser photocoagulation, being the commonly employed treatment protocols.


How to cite this article:
Shanmugam P M. Changing paradigms of anti-VEGF in the Indian scenario.Indian J Ophthalmol 2014;62:88-92


How to cite this URL:
Shanmugam P M. Changing paradigms of anti-VEGF in the Indian scenario. Indian J Ophthalmol [serial online] 2014 [cited 2020 Sep 22 ];62:88-92
Available from: http://www.ijo.in/article.asp?issn=0301-4738;year=2014;volume=62;issue=1;spage=88;epage=92;aulast=Shanmugam;type=0